Non Executive Director And Chair Of Audit And Risk Committee
CurrentGenEmbryomics ('GenEm') is pioneering genome sequencing of IVF embryos. By scanning all 20,000 genes in IVF embryos for risks linked to 6,000+ genetic diseases, GenEm unlocks answers to empower more informed family planning decisionsGenEm, through proprietary AI powered GenomeScreen ® platform, provides the first ever whole genome sequencing test for in vitro fertilization (IVF) that screens for every known genetic disease launched in 2023.The GenomeScreen ® platform provides whole genome sequencing of couples, parents and IVF embryos, enabling life's journey to be faced with deeper understanding and greater confidence.IVF clinics gain an actionable genome report to manage fertility with confidence; parents access the total information needed to choose the healthiest start for future generations.